 |
SV Life Sciences Fund I (SVLSFI)SVLSF I closed in 1994 with total commitments of $100 million. As at 31 December 2006, SVLSF I had invested $123 million in 31 portfolio companies. To go to individual portfolio companies websites please click
on company logo. 
Axys Pharmaceuticals: USFirst investment: 1994 - Early Stage - Exited Protease-inhibitor based products for cancer & inflammatory diseases. 
Cerebrus: UKFirst investment: 1995 - Start Up - Exited CNS drug discovery (Acquired by Nigra, which was then bought by Vernalis) Coral Therapeutics: US First investment: 1994 - Start Up - Exited Provision of blood handling services to hospitals. 
Cytomed: USFirst investment: 1997 - Early Stage - Exited Leukotriene inhibitors for asthma (Acquired by LeukoSite Inc and then by Millenium formerly known as Cytomed share). Euro Dentalversand: Germany First investment: 2000 - Buy Out - Exited Mail order dental consumables. 
Geltex Pharmaceuticals: USFirst investment: 1994 - Early Stage - Exited Further investment: 1998 - Expansion - Exited Development of novel non-absorbed pharmaceuticals. Acquired by Genzyme Corporation after our exit. 
General Surgical Innovations: USFirst investment: 1995 - Early Stage - Exited Minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical). 
Genosis: UKFirst investment: 1999 - Start Up Male and female home fertility diagnostics. 
Heritage Health Systems: USFirst investment: 1995 - Early Stage - Exited Physician practice management. 
Incyte Pharmaceuticals: UKFirst investment: 1996 - Start Up - Exited Functional genomics (Acquired by Incyte). Formerly known as Hexagen plc 
JC Nationwide: USFirst investment: 1995 - Buy Out - Exited Physician recruitment agency. 
Kinetix Pharmaceuticals: USFirst investment: 1999 - Start Up - Exited Kinase targeted drug discovery (Acquired by Amgen). 
Leica Microsystems: GermanyFirst investment: 1998 - Buy Out - Exited Manufactures and markets microscopes and neurosurgical equipment.
LeukoSite: USFirst investment: 1994 - Start Up - Exited Treatment of Inflammatory diseases and cancer (Acquired by Millenium). 
MedNova: IrelandFirst investment: 1996 - Start Up Devices for interventional radiology and cardiology. 
Metris Therapeutics: UKInvestment SVLSF I: 1998 - Start Up Investment SVLSF II: 2000 Treatment of gynaecological disorders. 
Micromass: UKFirst investment: 1996 - Buy Out - Exited Minimally invasive approach to hernia repair and incontinence (purchased by Waters). 
MicroMed: USFirst investment: 1998 - Early Stage Left ventricular assist devices 
Micromet: GermanyFirst investment: 1998 - Start Up Drug discovery using novel protein drugs Nexan: UK First investment: 1996 - Start Up - Exited Remote telemonitoring devices. 
OMS Foundations: USFirst investment: 1998 - Early Stage - Exited Oral maxillofacial physician practice management. 
Orthovita: USFirst investment: 1997 - Early Stage - Exited Novel bone substitute materials. Pelton & Crane: US First investment: 1997 - Buy Out - Exited Sterilization equipment 
Shire Pharmaceuticals: USFirst investment: 1994 - Early Stage - Exited Osteoporosis and Alzheimer's disease. 
Sirona Dental Systems: GermanyFirst investment: 1997 - Buy Out - Exited Dental equipment manufacturer. 
Strides Arcolab: IndiaFirst investment: 1997 - Expansion - Exited Manufacturer of generic pharmaceuticals. 
TLC Vision: USFirst investment: 1995 - Expansion - Exited Service provider for laser-based ophthalmic surgery. (Formerly known as LaserVision). 
Triangle Pharmaceuticals: USFirst investment: 1995 - Start Up - Exited Antiviral and anticancer drug development (Acquired by Gilead).
Vanguard Medica (Vernalis): UKFirst investment: 1995 - Early Stage - Exited Antiviral and anticancer drug development. (Acquired by Vernalis) Vintage BioMed: US First investment: 1996 - Seed - Exited Capital equipment leasing and maintenance. 
|
